Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Veta Smart Case, App for Epinephrine Auto-Injectors Now Available

Veta Smart Case, App for Epinephrine Auto-Injectors Now Available

By

The Smart Case includes electronics and sensors to monitor the proximity, temperature, presence and removal, and expiration of auto-injectors.

Walgreens to Offer Auvi-Q Nationwide in an Effort to Address Epinephrine Supply Issues

Walgreens to Offer Auvi-Q Nationwide in an Effort to Address Epinephrine Supply Issues

By

This effort is in response to epinephrine auto-injector supply issues reported by manufacturers to the Food and Drug Administration (FDA).

Xerava Approved for the Treatment of Complicated Intra-Abdominal Infections

Xerava Approved for the Treatment of Complicated Intra-Abdominal Infections

By

Eravacycline was well-tolerated in clinical trials and achieved high cure rates in patients with Gram-negative pathogens (including resistant strains).

Cassipa Approved as Maintenance Treatment for Opioid Dependence

Cassipa Approved as Maintenance Treatment for Opioid Dependence

By

Cassipa combines buprenorphine, an opioid (partial agonist-antagonist), and naloxone, an opioid antagonist.

Reducing HF Hospitalization Risk: Antidiabetic Drug Classes Compared

Reducing HF Hospitalization Risk: Antidiabetic Drug Classes Compared

By

The authors searched for randomized placebo-controlled trials (December 1, 2008 to November 24, 2017) involving 3 pharmacologic classes of antidiabetic medications to compare the effects of these agents on the risk of hospitalization for HF in T2DM patients.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-newsletters